Untreated Adult Acute Lymphoblastic Leukemia Withdrawn Phase 2 Trials for Leucovorin (DB00650)

Indication	Status	Phase
DBCOND0029290 (Untreated Adult Acute Lymphoblastic Leukemia)	Withdrawn	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01670084	Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia	Treatment	Coenzyme M (DB09110) Cyclophosphamide (DB00531) Cytarabine (DB00987) Dexamethasone (DB01234) Doxorubicin (DB00997) Leucovorin (DB00650) Methotrexate (DB00563) Nilotinib (DB04868) Prednisone (DB00635) Rituximab (DB00073) Sulfate ion (DB14546) Vincristine (DB00541)